ArticleAmerican journal of cancer research2022

Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinoma.

Wu Lin et al.PubMed ↗Full text ↗

No numbers read from the abstract.